ROCKROSE DEVELOPMENT CORP – Trademark Portfolio

Entity Type: 03

ROCKROSE DEVELOPMENT CORP holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 6 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ROCKROSE. The owner is based in NEW YORK, NY.

666 FIFTH AVENUE

NEW YORK, NY NEW YORK

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ROCKROSE DEVELOPMENT CORP's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (6 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

37
Building & Construction (2 filings)

Building construction; repair; installation services

Frequently Asked Questions

How many trademarks does ROCKROSE DEVELOPMENT CORP have?

ROCKROSE DEVELOPMENT CORP has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 3 cancelled.

What trademark classes does ROCKROSE DEVELOPMENT CORP file in?

ROCKROSE DEVELOPMENT CORP files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 37 (Building & Construction). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are ROCKROSE DEVELOPMENT CORP's most well-known trademarks?

ROCKROSE DEVELOPMENT CORP's registered trademark portfolio includes well-known marks such as ROCKROSE. These are among 3 currently registered trademarks in the portfolio.

What is ROCKROSE DEVELOPMENT CORP's trademark registration success rate?

ROCKROSE DEVELOPMENT CORP has a 43% trademark registration rate, with 3 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.